Annual EBITDA
-$63.32 M
+$93.30 K+0.15%
December 31, 2024
Summary
- As of March 10, 2025, SLN annual EBITDA is -$63.32 million, with the most recent change of +$93.30 thousand (+0.15%) on December 31, 2024.
- During the last 3 years, SLN annual EBITDA has fallen by -$2.02 million (-3.29%).
- SLN annual EBITDA is now -4296.85% below its all-time high of -$1.44 million, reached on December 31, 1995.
Performance
SLN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.66 M
+$22.01 M+76.76%
December 1, 2024
Summary
- As of March 10, 2025, SLN quarterly EBITDA is -$6.66 million, with the most recent change of +$22.01 million (+76.76%) on December 1, 2024.
- Over the past year, SLN quarterly EBITDA has stayed the same.
- SLN quarterly EBITDA is now -63.30% below its all-time high of -$4.08 million, reached on March 31, 2024.
Performance
SLN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$61.10 M
+$14.20 M+18.86%
December 1, 2024
Summary
- As of March 10, 2025, SLN TTM EBITDA is -$61.10 million, with the most recent change of +$14.20 million (+18.86%) on December 1, 2024.
- Over the past year, SLN TTM EBITDA has stayed the same.
- SLN TTM EBITDA is now -409.83% below its all-time high of -$11.98 million, reached on September 30, 2020.
Performance
SLN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | 0.0% | 0.0% |
| 3 y3 years | -3.3% | 0.0% | 0.0% |
| 5 y5 years | -116.0% | 0.0% | 0.0% |
SLN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.7% | +0.1% | -63.3% | +76.8% | -18.2% | +18.9% |
| 5 y | 5-year | -116.0% | +0.1% | -63.3% | +76.8% | -409.8% | +18.9% |
| alltime | all time | -4296.9% | +0.1% | -63.3% | +76.8% | -409.8% | +18.9% |
Silence Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$63.32 M(-0.1%) | - | - |
| Dec 2024 | - | -$6.66 M(-76.8%) | -$61.10 M(-18.9%) |
| Sep 2024 | - | -$28.67 M(+32.3%) | -$75.30 M(+26.6%) |
| Jun 2024 | - | -$21.68 M(+431.2%) | -$59.48 M(+15.1%) |
| Mar 2024 | - | -$4.08 M(-80.4%) | -$51.67 M(-16.7%) |
| Dec 2023 | -$63.41 M(+11.9%) | -$20.87 M(+62.3%) | -$62.06 M(-0.2%) |
| Sep 2023 | - | -$12.86 M(-7.3%) | -$62.20 M(+4.3%) |
| Jun 2023 | - | -$13.87 M(-4.1%) | -$59.62 M(-3.7%) |
| Mar 2023 | - | -$14.46 M(-31.2%) | -$61.90 M(+3.4%) |
| Dec 2022 | -$56.68 M(-7.5%) | -$21.01 M(+104.6%) | -$59.86 M(+10.3%) |
| Sep 2022 | - | -$10.27 M(-36.4%) | -$54.25 M(-9.5%) |
| Jun 2022 | - | -$16.15 M(+30.0%) | -$59.94 M(-2.1%) |
| Mar 2022 | - | -$12.43 M(-19.3%) | -$61.21 M(-0.4%) |
| Dec 2021 | -$61.30 M(+26.6%) | -$15.41 M(-3.5%) | -$61.44 M(-6.3%) |
| Sep 2021 | - | -$15.96 M(-8.4%) | -$65.59 M(+6.5%) |
| Jun 2021 | - | -$17.42 M(+37.6%) | -$61.61 M(+39.4%) |
| Mar 2021 | - | -$12.66 M(-35.3%) | -$44.20 M(+40.1%) |
| Dec 2020 | -$48.42 M(+65.2%) | -$19.55 M(+63.2%) | -$31.54 M(+163.2%) |
| Sep 2020 | - | -$11.98 M | -$11.98 M |
| Dec 2019 | -$29.31 M(+14.8%) | - | - |
| Dec 2018 | -$25.54 M(+468.0%) | - | - |
| Dec 2017 | -$4.50 M(-68.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$14.31 M(+0.7%) | - | - |
| Dec 2015 | -$14.20 M(-22.6%) | - | - |
| Dec 2014 | -$18.36 M(+26.9%) | - | - |
| Dec 2013 | -$14.47 M(+68.7%) | - | - |
| Dec 2012 | -$8.58 M(+1.9%) | - | - |
| Dec 2011 | -$8.41 M(-35.2%) | - | - |
| Dec 2010 | -$12.98 M(+30.4%) | - | - |
| Dec 2009 | -$9.95 M(-8.7%) | - | - |
| Dec 2008 | -$10.90 M(+3.4%) | - | - |
| Dec 2007 | -$10.54 M(+50.1%) | - | - |
| Dec 2006 | -$7.03 M(+19.5%) | - | - |
| Dec 2005 | -$5.88 M(-4.1%) | - | - |
| Dec 2004 | -$6.13 M(+30.7%) | - | - |
| Dec 2003 | -$4.69 M(+49.5%) | - | - |
| Dec 2002 | -$3.14 M(-27.6%) | - | - |
| Dec 2001 | -$4.34 M(+7.3%) | - | - |
| Dec 2000 | -$4.04 M(+15.0%) | - | - |
| Dec 1999 | -$3.52 M(+13.4%) | - | - |
| Dec 1998 | -$3.10 M(-11.8%) | - | - |
| Dec 1997 | -$3.51 M(+69.5%) | - | - |
| Dec 1996 | -$2.07 M(+43.9%) | - | - |
| Dec 1995 | -$1.44 M | - | - |
FAQ
- What is Silence Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Silence Therapeutics?
- What is Silence Therapeutics annual EBITDA year-on-year change?
- What is Silence Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Silence Therapeutics?
- What is Silence Therapeutics quarterly EBITDA year-on-year change?
- What is Silence Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Silence Therapeutics?
- What is Silence Therapeutics TTM EBITDA year-on-year change?
What is Silence Therapeutics annual EBITDA?
The current annual EBITDA of SLN is -$63.32 M
What is the all time high annual EBITDA for Silence Therapeutics?
Silence Therapeutics all-time high annual EBITDA is -$1.44 M
What is Silence Therapeutics annual EBITDA year-on-year change?
Over the past year, SLN annual EBITDA has changed by +$93.30 K (+0.15%)
What is Silence Therapeutics quarterly EBITDA?
The current quarterly EBITDA of SLN is -$6.66 M
What is the all time high quarterly EBITDA for Silence Therapeutics?
Silence Therapeutics all-time high quarterly EBITDA is -$4.08 M
What is Silence Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SLN quarterly EBITDA has changed by $0.00 (0.00%)
What is Silence Therapeutics TTM EBITDA?
The current TTM EBITDA of SLN is -$61.10 M
What is the all time high TTM EBITDA for Silence Therapeutics?
Silence Therapeutics all-time high TTM EBITDA is -$11.98 M
What is Silence Therapeutics TTM EBITDA year-on-year change?
Over the past year, SLN TTM EBITDA has changed by $0.00 (0.00%)